Recent News

• 05.28.2025 - iTeos Therapeutics Announces Its Intention to Wind Down Operations
• 05.28.2025 - iTeos Therapeutics Announces Its Intention to Wind Down Operations
• 05.13.2025 - iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients
• 05.13.2025 - iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients

Recent Filings

• 05.19.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership